Associated Papers
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.
Kooijman JJ et al.
Frontiers in Oncology, 2022
Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
Akahane T et al.
Bmc Medical Genomics, 2020
32652986 (PubMed )
Supplement: 12920_2020_753_MOESM2_ESM.xlsx › Sheet1
Mutation and drug-specific intracellular accumulation of EGFR predict clinical responses to tyrosine kinase inhibitors.
de Wit M et al.
Ebiomedicine, 2020
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.
Jin Y et al.
Oncogene, 2020
Molecular Alterations in Pulmonary Adenocarcinoma of African Americans.
Rodriguez EF et al.
American Journal of Clinical Pathology, 2019
Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK et al.
Cancer Cell, 2018
Clinical mutational profiling of 1006 lung cancers by next generation sequencing.
Illei PB et al.
Oncotarget, 2017
29228562 (PubMed )
Supplement: oncotarget-08-96684-s002.docx
Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Lee JK et al.
Nature Genetics, 2017
Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients.
Tong L et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2012
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.
Fumagalli D et al.
Bmc Cancer, 2010
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma.
Idbaih A et al.
Neuropathology and Applied Neurobiology, 2009
Select a paper to view details